Dräger’s Atlan A350/A350XL Anesthesia Workstations Achieve U.S. DoD ATO Certification for Maximum Patient Data Security

Certification ensures highest level of patient data security a medical device can attain Effective 7/14/2025 and expiring on 7/14/2028 under eMASS ...

August 12, 2025 | Tuesday | News
Nyxoah Secures FDA Approval for Genio System to Treat Moderate to Severe Obstructive Sleep Apnea

Nyxoah SA , a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, ann...

August 11, 2025 | Monday | News
Anbio Launches Chikungunya Rapid Test and Ultra-Fast PCR System to Strengthen Global Outbreak Response

Anbio Biotechnology has announced the launch of its Chikungunya IgM/IgG Rapid Test, offering clinicians and public health authorities a fast, accessible ...

August 11, 2025 | Monday | News
Taiwan’s Brain Navi and Spain’s Palex Launch NaoTrac with First Hospital Installation in Spain

Such an achievement has been made possible through the first of many collaborations with our valued partner, Palex Healthcare. This milestone has be...

August 08, 2025 | Friday | News
Exact Sciences Secures Exclusive U.S. Rights to Freenome’s Blood-Based Colorectal Cancer Screening Tests

Exact Sciences acquires exclusive rights to current and future versions of Freenome’s blood-based colorectal cancer screening tests Freenome sub...

August 07, 2025 | Thursday | News
MediSpend Acquires Alucio to Elevate AI-Driven Scientific Engagement for Life Sciences

MediSpend, a global leading provider of compliance and stakeholder engagement solutions for the life sciences industry, announces its acquisition of Aluc...

August 05, 2025 | Tuesday | News
FUJIFILM Launches FDR Go iQ in the U.S., Redefining Mobile X-Ray Imaging with Smart Design and AI-Ready Innovation

-FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, today announced the U.S. launch of the FDR ...

July 31, 2025 | Thursday | News
FDA Approves Apellis’ EMPAVELI® as First-Ever Treatment for Rare Kidney Diseases C3G and IC-MPGN

Apellis Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved EMPAVELI® (pegcetacoplan) as the first tre...

July 29, 2025 | Tuesday | News
Roche’s Elecsys pTau181 Becomes First IVDR-Certified Blood Test to Rule Out Alzheimer’s Pathology

Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test to rule out Alzheimer’s associated amyloid pathology. The mini...

July 23, 2025 | Wednesday | News
Corteria Pharmaceuticals Advances Dual CRF2 Agonist Pipeline for Heart Failure and Obesity

Corteria Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development of transformative therapies for heart failure and obesity, ...

July 22, 2025 | Tuesday | News
Longeveron Licenses Breakthrough Stem Cell Patent to Expand Cardiac Regenerative Pipeline

 Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, ra...

July 22, 2025 | Tuesday | News
Acumen and JCR Pharmaceuticals Partner to Develop Enhanced Brain Delivery Therapy for Alzheimer’s Disease

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a ...

July 16, 2025 | Wednesday | News
CDX Medical Secures $2.5M Series A to Advance Next-Generation ECMO Platform

CDX Medical Technologies (CDX), a pioneer in extracorporeal membrane oxygenation (ECMO) pump innovation, today announced the successful close of its $2.5...

July 15, 2025 | Tuesday | News
Angelini Ventures Co-Leads CHF79M Series B in NUCLIDIUM to Advance Copper-Based Radiotheranostics

  Angelini Ventures, the corporate venture firm of Angelini Industries focused on investing in companies developing innovative solutions in BioTech a...

July 11, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close